Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Assets (2016 - 2025)

Historic Assets for Alkermes (ALKS) over the last 15 years, with Q3 2025 value amounting to $2.3 billion.

  • Alkermes' Assets rose 808.34% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 808.34%. This contributed to the annual value of $2.1 billion for FY2024, which is 377.56% down from last year.
  • As of Q3 2025, Alkermes' Assets stood at $2.3 billion, which was up 808.34% from $2.3 billion recorded in Q2 2025.
  • Alkermes' Assets' 5-year high stood at $2.3 billion during Q3 2025, with a 5-year trough of $1.9 billion in Q1 2021.
  • For the 5-year period, Alkermes' Assets averaged around $2.1 billion, with its median value being $2.1 billion (2024).
  • As far as peak fluctuations go, Alkermes' Assets surged by 1737.12% in 2023, and later tumbled by 543.78% in 2024.
  • Quarter analysis of 5 years shows Alkermes' Assets stood at $2.0 billion in 2021, then fell by 2.99% to $2.0 billion in 2022, then grew by 8.77% to $2.1 billion in 2023, then decreased by 3.78% to $2.1 billion in 2024, then rose by 13.33% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q3 2025, $2.3 billion for Q2 2025, and $2.1 billion during Q1 2025.